A GSK logo is seen on the side of an office building in Poznan, Poland. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...
India's GlaxoSmithKline Pharmaceuticals reported slightly higher second-quarter profit on Thursday, led by steady demand for ...
A new agreement between GlaxoSmithKline (GSK) and VentureWise—part of the MedicineWise Group—will see an independent educational program delivered to GPs on the topic of chronic obstructive pulmonary ...
In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £15.50. The company’s shares opened today at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback